Books by "Philip H. Kirsch"
2 books found
History, travelogue, and memoir combine in this illuminating journey in the footsteps of the great explorer La Salle. This is the extraordinary account of a personal and historical quest in which Philip Marchand retraces the seventeenth-century explorations of La Salle while he searches in the present day for vestiges of France’s lost North American legacy. After he explored the Great Lakes and the entire Mississippi, La Salle was murdered by his own men when he led them on a disastrous mission to Texas. The vast land beyond Quebec that he claimed for France could have become — but for a few twists of history — an alternative North America: a French-speaking, Catholic empire in which native peoples would have played a prominent role. Marchand probes the intriguingly flawed character of La Salle and recounts the astonishing history of the Jesuit missionaries, coureurs de bois, fur traders, and soldiers who followed on his heels, and of the Indian nations with whom they came into contact. He also reports on the survivals of this diaspora from late-night bars, battle reenactments, parish churches, and wayside restaurants from Montreal to Venice, Louisiana. And throughout he draws on memories of his own Catholic childhood in Massachusetts to interpret the lingering attitudes, fears, hopes, and iconography of a people who, more deeply than most, feel the burdens and the ironies of history.
Managing Discovery in the Life Sciences
by Philip A. Rea, Mark V. Pauly, Lawton R. Burns
2018 · Cambridge University Press
In this book, distinguished scholars Philip A. Rea, Mark V. Pauly, and Lawton R. Burns explore the science and management behind marketable biomedical innovations. They look at how the science actually played out through the interplay of personalities, the cultures within and between academic and corporate entities, and the significance of serendipity not as a mysterious phenomenon but one intrinsic to the successes and failures of the experimental approach. With newly aggregated data and case studies, they consider the fundamental economic underpinnings of investor-driven discovery management, not as an obstacle or deficiency as its critics would contend or as something beyond reproach as some of its proponents might claim, but as the only means by which scientists and managers can navigate the unknowable to discover new products and decide how to sell them so as to maximize the likelihood of establishing a sustainable pipeline for still more marketable biomedical innovations.